| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate |
2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a26bd745c953ff78961098d77d3223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e9946e815533656d30d0fb99b36745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36d467b234203ef1d2c7bd2e471bc68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dfe359f0d9693b8ade21eef209e9043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b04b48eb1fda09e43296dac719f1af5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd92b62b43e6ac71ed528a0dc1b6e24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b6c17eb6b0593d8d44d2755c842ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0698d25f453de7a4a1821d7bf10352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bc238bbc56cd1198c82297fd84ced3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e68b282615e8d6316c30fa5232112c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6534575548e2f355d4935dd768aa98e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246f4d67226c8928fa43641c3ca7e6ad |
| publicationDate |
2011-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7893055-B2 |
| titleOfInvention |
HIV integrase inhibitors |
| abstract |
The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011245241-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010216774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383639-B2 |
| priorityDate |
2006-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |